Johnson & Johnson
Feb 23, 2017
FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation
Dec 29, 2015
OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers
Oct 14, 2015
OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.